Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03362723
Title A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Colorado Aurora Colorado 80045-2517 United States Details
Yale Cancer Center; Medical Oncology New Haven Connecticut 06520 United States Details
Washington University; Wash Uni. Sch. Of Med Saint Louis Missouri 63110 United States Details
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley Las Vegas Nevada 89169 United States Details
University of Oklahoma Health Sciences Center; Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
New Orleans Center for Clinical Research Knoxville Tennessee 37920 United States Details
Mary Crowley Medical Research Center Dallas Texas 75230 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Princess Margaret Cancer Center Toronto Ontario M5G 1Z5 Canada Details
Jewish General Hospital / McGill University Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field